Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Genetic polymorphisms of CYP3A5 and UGT1A9 and pharmacokinetics of tacrolimus and mycophenolate in liver transplantation
TCTR20190707002Phase 2Recruiting
- Sponsor
- Ratchadaphiseksomphot Endowment Fund
- Start
- May 2019
- Modality
- RNA-Targeting Small Molecules → Nucleic Acid-Directed Small Molecules → Small Molecules, Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of tacrolimus, mycophenolate in hepatic disease, sponsored by Ratchadaphiseksomphot Endowment Fund. Started May 2019; status: recruiting.
02
Drugs
tacrolimusmycophenolate
03
Conditions
hepatic disease
Beyond the preview
Go deeper on TCTR20190707002.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on TCTR20190707002.